ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 946,40
-0,20%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Freeline Therapeutics Holdings PLC (FRLN)

  7. Freeline Therapeutics Holdings PLC (FRLN) Actualités

FRLN Freeline Therapeutics Holdings PLC

6,48
0,00 (0,00%)
17 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Freeline Therapeutics Holdings PLC FRLN NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 6,48 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,48 6,48
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:00GLOBEFreeline to Present New Data on its Gaucher and Parkinson’s..
26/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/2/202422:38EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/2/202422:28EDGAR2Form POS AM - Post-Effective amendments for registration..
20/2/202421:22EDGAR2Form SC 13E3/A - Going private transaction by certain..
20/2/202413:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202413:00GLOBEAcquisition of Freeline by Syncona Becomes Effective
12/2/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202418:00GLOBEFreeline Shareholders Approve Acquisition by Syncona
18/1/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202422:17EDGAR2Form SC 13E3/A - Going private transaction by certain..
08/12/202323:21EDGAR2Form SC 13E3 - Going private transaction by certain issuers
01/12/202314:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202315:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202313:30GLOBESyncona to Acquire Freeline Therapeutics
25/10/202312:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202308:01GLOBEFreeline Presents Positive New Data from Phase 1/2 GALILEO-1..
18/10/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202313:00GLOBEFreeline to Present New Clinical Data for FLT201 in Gaucher..
06/10/202322:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202313:00GLOBEFreeline Reports Positive Initial Clinical Data from First..
15/8/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202313:00GLOBEFreeline Reports Second Quarter 2023 Financial Results and..
08/8/202313:30GLOBEFreeline Therapeutics to Host Second Quarter 2023 Financial..
31/7/202313:30GLOBEFreeline to Participate in Upcoming Investor Conferences
25/7/202313:30GLOBEFreeline to Host Virtual KOL Event on its Gene Therapy..
26/6/202313:30GLOBEFreeline Announces First Patient Dosed with Its Novel Gene..
02/6/202314:00GLOBEFreeline to Present at 2023 Jefferies Healthcare Conference
30/5/202313:30GLOBEFreeline Reports First Quarter 2023 Financial Results and..
22/5/202314:00GLOBEFreeline Granted ILAP Designation in United Kingdom by MHRA..

Dernières Valeurs Consultées

NASDAQ
FRLN
Freeline Therapeutics
LSE
80YE
BIT
UC2UDQ
Unicredit Bank
USOTC
SSET
Starstream Entertainment (PK)
BIT
UC4VCN
Unicredit Bank
BIT
UC2A0M
Unicredit Bank
COIN
CDSEUR
BTHB
BASICKRW
BASIC Token
MRTX
BYRONETH
Byron
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés